Amanote Research

Amanote Research

    RegisterSign In

How to Overcome Endocrine Resistance in Early and Metastatic Breast Cancer

Chronicles of Oncology
doi 10.33582/2638-4248/1005
Full Text
Open PDF
Abstract

Available in full text

Date

June 22, 2018

Authors
Ewelina BiskupMarcus Vetter
Publisher

MedDocs Publishers LLC


Related search

Mechanisms of Development and the Ways to Overcome Endocrine Resistance in Breast Cancer

Malignant tumours
2015English

How to Improve Endocrine Therapy of Breast Cancer

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
1990English

Predicting Response/Resistance to Endocrine Therapy for Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2005English

Late Recurrences in Early Breast Cancer: For Whom and How Long Is Endocrine Therapy Beneficial?

Breast Care
SurgeryOncology
2014English

Personalized Drug Combinations to Overcome Trastuzumab Resistance in HER2-positive Breast Cancer

Biochimica et Biophysica Acta - Reviews on Cancer
Cancer ResearchOncologyGenetics
2014English

Addition of Everolimus and Trastuzumab to Endocrine Therapy in Hormone-Refractory Metastatic Breast Cancer

Clinical Breast Cancer
Cancer ResearchOncology
2019English

Adjuvant Endocrine Therapy in Early Postmenopausal Breast Cancer

Breast Care
SurgeryOncology
2008English

HER2-Orientated Therapy in Early and Metastatic Breast Cancer

Breast Care
SurgeryOncology
2016English

Mechanisms Behind the Resistance to Trastuzumab in HER2-Amplified Breast Cancer and Strategies to Overcome It

Clinical Medicine Insights: Oncology
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy